Hints and tips:
Related Special Reports
...The lawyer told the Financial Times that German media reports painting him as a conspiracy theorist showed he was “doing a good job” of scaring the pharmaceutical companies....
...Takeda has adopted a cautious approach to investing in vaccines and has a limited pipeline of opportunities....
...Mexico has agreed to host human trials of seven Covid-19 vaccines to strengthen relations with pharmaceutical companies in case limited production capacity leads to a battle for doses....
...Adenovirus-based vaccines, such as Gamaleya’s Sputnik V, Oxford-AstraZeneca’s and Johnson & Johnson’s, for example, are limited by how much information they can hold and what the vaccines can be instructed...
...A committee of Indian pharmaceutical and medical experts has recommended the use of Russia’s Sputnik V coronavirus vaccine to alleviate pressure on the country’s limited supplies as it faces a second wave...
...Shareholders were rightly worried by Takeda’s $62bn acquisition of London-listed rival Shire two years ago. The Japanese pharmaceuticals group is still weighed down by the resulting debt....
...But the companies partnering with RDIF have limited vaccine experience and will need time to establish production lines to make Sputnik V, according to analysts....
...Despite limited uptake so far outside China, Sinopharm has wasted little time in expanding its ability to manufacture the Covid-19 vaccines....
...Eurosceptic Orban has maintained close ties with Russian president Vladimir Putin, while Budapest has awarded the largest infrastructure project in the country to Chinese companies and committed to open...
...At the time, the company said the fire killed five workers and that it would not affect production of the AstraZeneca vaccine....
...But judging from limited pricing information, Sinopharm’s jabs also appear to be among the most expensive options available....
...In China, the authorities have allowed the limited use of several vaccines since the summer and gave conditional approval to a vaccine developed by state-owned Sinopharm in December after the company said...
...The commission has secured deals for more than a billion doses of coronavirus jabs with a range of pharmaceutical companies, in an effort to standardise their availability and use across the EU....
...Health officials said this would only happen under very limited circumstances. Mary Ramsay, Head of Immunisations at PHE, said mixing Covid-19 vaccines was not recommended....
...The minister said he was also in talks with a Hungarian pharmaceutical company to see if it would be able to produce the vaccine....
...bedevilling other European governments which are competing with each other for vaccines manufactured by pharmaceutical companies, or squabbling over how to divide up pooled orders....
...So Ramaphosa and health minister Zweli Mkhize scrambled to negotiate with pharmaceutical companies, acquiring 1.5m doses of the Oxford/AstraZeneca jab....
...Bessemer said it supported his decision, and he would become an adviser and “special limited partner”....
...Third, access will be limited by budgets in poorer nations, with initial supplies reserved by a few richer countries which have placed advanced orders with companies....
...“The ethnic diversity, the age diversity, the gender diversity was pretty limited, which means that . . . you’re not going to pick up rarer safety issues,” he added....
...Idexx said in October that the animal health market had experienced a “V-shaped recovery”....
...“The investment required is too large for any company,” said Christophe Weber, chief executive of Takeda, the Japanese drugs and vaccines company. “Society will have to finance this huge investment....
...Contraction was the watchword for the whole of the UK economy, with only the pharmaceuticals sector recording growth....
...Further, the UK regulator’s recent stress tests commentary suggest limited risk for life companies. L&G's business is broadly resilient to COVID-19 shocks, in our view....
International Edition